Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia

BMC Pediatrics

Table 2 Lipid apheresis: Lipid levels at baseline and after 3 years of lipid apheresis

Patient	LDL-C [mg/dL] on max. Oral medication	Steady state Pre-LA LDL-C [mg/dL]	Steady state Post-LA LDL-C [mg/dL]
1	688.8^a	411.2 (288.8-564.6)	153.5 (113.8-227.8)
2	535.4 (534.8-536.0)	337.2 (265.0-443.0)	104.7 (84.8-151.6)
3	597.1 (521.2-732.0)	244.2^b (223.0-287.4)	81.0^b (67.4-99.0)
4	742.0^a	251.7 (205.0-297.4)	76.4 (57.2-94.8)

Values at baseline are on maximum oral medication with statins and ezetimibe in all patients and colesevelam in Patient 2. Lipid values were measured before and after weekly/biweekly LA. Values are displayed as means, minimum and maximum over a period of 3 months. ^aonly one measurement available. ^bbiweekly

ISSN: 1471-2431